UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Leukemia, 2019-04, Vol.33 (4), p.1023-1029

2019

Volltextzugriff (PDF)

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

American journal of hematology, 2018-06, Vol.93 (6), p.803-809

2018

Volltextzugriff (PDF)

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

American journal of hematology, 2022-02, Vol.97 (2), p.203-208

2022

Volltextzugriff (PDF)

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

Leukemia, 2022-02, Vol.36 (2), p.573-576

2022

Volltextzugriff (PDF)

Pulmonary manifestations of Erdheim–Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis

British journal of haematology, 2021-09, Vol.194 (6), p.1024-1033

2021

Volltextzugriff (PDF)

Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement

Heart (British Cardiac Society), 2024-05, Vol.110 (13), p.899-907

2024

Volltextzugriff (PDF)

A highly heterogeneous mutational pattern in POEMS syndrome

Leukemia, 2021-04, Vol.35 (4), p.1100-1107

2021

Volltextzugriff (PDF)

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia

Orphanet journal of rare diseases, 2024-05, Vol.19 (1), p.185-185, Article 185

2024

Volltextzugriff (PDF)

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

Annals of hematology, 2022-04, Vol.101 (4), p.831-836

2022

Volltextzugriff (PDF)

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

American journal of hematology, 2020-09, Vol.95 (9), p.E235-E238

2020

Volltextzugriff (PDF)

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Blood cancer journal (New York), 2021-08, Vol.11 (8), p.145-145, Article 145

2021

Volltextzugriff (PDF)

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

PloS one, 2020-02, Vol.15 (2), p.e0229089-e0229089

2020

Volltextzugriff (PDF)

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis

Leukemia, 2024-04, Vol.38 (4), p.803-809

2024

Volltextzugriff (PDF)

Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma

Cell proliferation, 2019-05, Vol.52 (3), p.e12600-n/a

2019

Volltextzugriff (PDF)

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

Journal of cellular and molecular medicine, 2021-08, Vol.25 (16), p.7901-7912

2021

Volltextzugriff (PDF)

Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients

Scientific reports, 2020-07, Vol.10 (1), p.12694, Article 12694

2020

Volltextzugriff (PDF)

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

BMC cancer, 2020-09, Vol.20 (1), p.911-911, Article 911

2020

Volltextzugriff (PDF)

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells

Journal of cellular and molecular medicine, 2019-10, Vol.23 (10), p.6942-6954

2019

Volltextzugriff (PDF)

Bortezomib-based chemotherapy can improve renal and tubular functions in patients with light chain-associated Fanconi syndrome

Annals of hematology, 2019-05, Vol.98 (5), p.1095-1100

2019

Volltextzugriff (PDF)

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study

Haematologica (Roma), 2024-07, Vol.109 (7), p.2355

2024

Volltextzugriff (PDF)

A 47-Year-Old Woman With Progressive Exertional Dyspnea and Fatigue

Chest, 2022-02, Vol.161 (2), p.e81-e84

2022

Volltextzugriff (PDF)

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Annals of hematology, 2020-08, Vol.99 (8), p.1735-1740

2020

Volltextzugriff (PDF)

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease

Orphanet journal of rare diseases, 2019-01, Vol.14 (1), p.11-11, Article 11

2019

Volltextzugriff (PDF)

Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease

Annals of hematology, 2018, Vol.97 (1), p.185-187

2018

Volltextzugriff (PDF)

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Circulation (New York, N.Y.), 2022-01, Vol.145 (1), p.8-17

2022

Volltextzugriff (PDF)

1 – 25 von 1.183

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Complete

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(905)
Mit Volltextzugriff
(946)

Publikationsform

Artikel
(1.183)

Sprache

Englisch
(967)
Chinesisch
(221)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(21)

Menü

Weitere Dienste

Einstellungen

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

Pulmonary manifestations of Erdheim–Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis

Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement

A highly heterogeneous mutational pattern in POEMS syndrome

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis

Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells

Bortezomib-based chemotherapy can improve renal and tubular functions in patients with light chain-associated Fanconi syndrome

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study

A 47-Year-Old Woman With Progressive Exertional Dyspnea and Fatigue

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease

Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Aktive Filter

Suchergebnisse filtern